Shandong Bailong Chuangyuan Bio-Tech Co.,Ltd.’s Net Profit Rose 57.2% in First Three Quarters of 2022

Shandong Bailong Chuangyuan Bio-Tech Co.,Ltd. (山东百龙创园生物科技股份有限公司) (605016.SH) reported a net profit of 118 million yuan in the first three quarters of 2022, up 57.2% year-on-year.

Meanwhile, the company posted 550.4 million yuan in revenue, up 16.6% year-on-year.

At the end of the reporting period, it had 1.4 billion yuan in total assets and 89.8 million yuan in total liabilities, with a liability-to-asset ratio of 6.4%.